These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 19637104)
1. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Sarid-Segal O; Knapp CM; Burch W; Richardson MA; Bahtia S; DeQuattro K; Afshar M; Richambault C; Sickels L; Devine E; Ciraulo DA Am J Drug Alcohol Abuse; 2009; 35(5):316-9. PubMed ID: 19637104 [TBL] [Abstract][Full Text] [Related]
2. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171 [TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled trial of zonisamide for the treatment of alcohol dependence. Arias AJ; Feinn R; Oncken C; Covault J; Kranzler HR J Clin Psychopharmacol; 2010 Jun; 30(3):318-22. PubMed ID: 20473070 [TBL] [Abstract][Full Text] [Related]
4. Zonisamide decreases ethanol intake in rats and mice. Knapp CM; Mercado M; Markley TL; Crosby S; Ciraulo DA; Kornetsky C Pharmacol Biochem Behav; 2007 May; 87(1):65-72. PubMed ID: 17482246 [TBL] [Abstract][Full Text] [Related]
5. Differentiating the contribution of pharmacological from alcohol expectancy effects to changes in subjective response and priming over successive drinks. Rose AK; Hobbs M; Drummond C Alcohol Clin Exp Res; 2013 Apr; 37(4):687-95. PubMed ID: 23075384 [TBL] [Abstract][Full Text] [Related]
6. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Miranda R; MacKillop J; Monti PM; Rohsenow DJ; Tidey J; Gwaltney C; Swift R; Ray L; McGeary J Alcohol Clin Exp Res; 2008 Mar; 32(3):489-97. PubMed ID: 18215213 [TBL] [Abstract][Full Text] [Related]
7. The Impact of Zonisamide on the Development and Course of Alcohol Dependence in Rabbits. A pharmaco-EEG study. Krupa-Burtnik A; Zwierzynska E; Kordala A; Pietrzak B Alcohol Alcohol; 2017 May; 52(3):282-288. PubMed ID: 28339635 [TBL] [Abstract][Full Text] [Related]
8. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers. Vatsalya V; Gowin JL; Schwandt ML; Momenan R; Coe MA; Cooke ME; Hommer DW; Bartlett S; Heilig M; Ramchandani VA Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26209857 [TBL] [Abstract][Full Text] [Related]
9. Exposure-Response Relationships during Free-Access Intravenous Alcohol Self-Administration in Nondependent Drinkers: Influence of Alcohol Expectancies and Impulsivity. Stangl BL; Vatsalya V; Zametkin MR; Cooke ME; Plawecki MH; O'Connor S; Ramchandani VA Int J Neuropsychopharmacol; 2017 Jan; 20(1):31-39. PubMed ID: 27742833 [TBL] [Abstract][Full Text] [Related]
10. Zonisamide for weight loss in obese adults: a randomized controlled trial. Gadde KM; Franciscy DM; Wagner HR; Krishnan KR JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361 [TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: Results from two human laboratory studies. Farokhnia M; Portelli J; Lee MR; McDiarmid GR; Munjal V; Abshire KM; Battista JT; Browning BD; Deschaine SL; Akhlaghi F; Leggio L Brain Res; 2020 Aug; 1740():146851. PubMed ID: 32339499 [TBL] [Abstract][Full Text] [Related]
12. Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals. Farokhnia M; Grodin EN; Lee MR; Oot EN; Blackburn AN; Stangl BL; Schwandt ML; Farinelli LA; Momenan R; Ramchandani VA; Leggio L Mol Psychiatry; 2018 Oct; 23(10):2029-2038. PubMed ID: 29133954 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of doxasozin and zonisamide on voluntary ethanol intake in mice that experienced chronic intermittent ethanol exposure and stress. Lopez MF; Reasons SE; Carper BA; Nolen TL; Williams RL; Becker HC Alcohol; 2020 Dec; 89():37-42. PubMed ID: 32712186 [TBL] [Abstract][Full Text] [Related]
14. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Schmidt D; Jacob R; Loiseau P; Deisenhammer E; Klinger D; Despland A; Egli M; Bauer G; Stenzel E; Blankenhorn V Epilepsy Res; 1993 May; 15(1):67-73. PubMed ID: 8325280 [TBL] [Abstract][Full Text] [Related]
15. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267 [TBL] [Abstract][Full Text] [Related]
16. Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome. Rubio G; López-Muñoz F; Ponce G; Pascual JM; Martínez-Gras I; Ferre F; Jiménez-Arriero MÁ; Alamo C Pharmacopsychiatry; 2010 Nov; 43(7):257-62. PubMed ID: 20927698 [TBL] [Abstract][Full Text] [Related]
17. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Knapp CM; Sarid-Segal O; Richardson MA; Colaneri LS; Afshar M; Devine E; Streeter CC; Piechniczek-Buczek J; Ciraulo DA Am J Drug Alcohol Abuse; 2010 Mar; 36(2):102-5. PubMed ID: 20337506 [TBL] [Abstract][Full Text] [Related]
19. Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study. de Wit H; Doty P Psychopharmacology (Berl); 1994 Aug; 115(4):529-38. PubMed ID: 7871098 [TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]